Strategic Partnerships Petra Pharma Corporation has established strategic collaborations with key players like Accelerator Life Science Partners and Evotec SE, indicating potential joint sales opportunities and partnerships in the biotechnology sector.
Expansion into Clinical Trials The launch of Phase 1b/2 study of serabelisib by Petra Pharma Corporation demonstrates a focus on clinical development, presenting potential sales avenues for clinical trial services, pharmaceutical supplies, and research partnerships.
Leadership Development Recruitment of Albert S. Yu as the Chief Medical Officer showcases Petra Pharma Corporation's commitment to enhancing expertise within the organization, highlighting potential sales collaborations with leading professionals and medical research institutions in the industry.
Series A Funding Securing $48 million in Series A funding positions Petra Pharma Corporation for growth and increased investment in research and development, offering sales opportunities for financial services, investment advisory firms, and strategic partnerships.
Targeted Therapeutics Petra Pharma Corporation's focus on developing novel therapeutics for cancer and metabolic diseases presents sales opportunities for specialized drug discovery services, personalized medicine technologies, and oncology-focused pharmaceutical companies seeking partnerships.
$100M$1B
$10M$50M
$50M$100M
$10M$50M
$10M$50M
$10MPetra Pharma Corporation uses 8 technology products and services including Google Analytics, WordPress, Twitter Emoji (Twemoji), and more. Explore Petra Pharma Corporation's tech stack below.
| Petra Pharma Corporation Email Formats | Percentage |
| FLast@petrapharmacorp.com | 38% |
| Last@petrapharmacorp.com | 12% |
| FLast@petrapharmacorp.com | 38% |
| Last@petrapharmacorp.com | 12% |
Biotechnology ResearchNew York, United States11-50 Employees
Petra Pharma is a drug development company focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. Petra Pharma will develop novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health.
Company Overview
Funding & FinancialsPetra Pharma Corporation has raised a total of $48M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2016 in the amount of $48Mas a Series A.
Funding & FinancialsPetra Pharma Corporation has raised a total of $48M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2016 in the amount of $48Mas a Series A.
1-888-653-2347 
support@leadiq.com